About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Ezetimibe / simvastatin
- Procedure number
- PSUSA/00001347/201903
- Regulatory outcome
- Variation
Documents
Ezetimibe / simvastatin: List of nationally authorised medicinal products - PSUSA/00001347/201903
English (EN) (387.95 KB - PDF)
Ezetimibe / simvastatin: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001347/201903
English (EN) (97.81 KB - PDF)
български (BG) (264.38 KB - PDF)
español (ES) (225.75 KB - PDF)
čeština (CS) (268.23 KB - PDF)
dansk (DA) (217.84 KB - PDF)
Deutsch (DE) (228.66 KB - PDF)
eesti keel (ET) (218.24 KB - PDF)
ελληνικά (EL) (292.93 KB - PDF)
français (FR) (231.27 KB - PDF)
hrvatski (HR) (287.51 KB - PDF)
íslenska (IS) (214.75 KB - PDF)
italiano (IT) (218.68 KB - PDF)
latviešu valoda (LV) (230.07 KB - PDF)
lietuvių kalba (LT) (288.37 KB - PDF)
magyar (HU) (280.46 KB - PDF)
Malti (MT) (241.78 KB - PDF)
Nederlands (NL) (225.42 KB - PDF)
norsk (NO) (196.66 KB - PDF)
polski (PL) (288.95 KB - PDF)
português (PT) (219.33 KB - PDF)
română (RO) (308.54 KB - PDF)
slovenčina (SK) (275.41 KB - PDF)
slovenščina (SL) (268.09 KB - PDF)
Suomi (FI) (216.13 KB - PDF)
svenska (SV) (216.94 KB - PDF)